Form D · Biotechnology

Genesis New Ventures, LLC

Missoula, MT · CIK 0001937493

Offering snapshot reported Apr 30, 2026 · SEC filing

Reported sold: $4.23M
Investors reported: 19
Minimum accepted: $50K
First sale: Mar 7, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$550,000 → $4,227,939
Reported investors3 → 19
Minimum accepted$150,000 → $50,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 30, 2026	Amendment	$4,227,939	$3,677,939vs Apr 29, 2025	19	SEC filing
Apr 29, 2025	Initial	$550,000	No comparison	3	SEC filing
Jul 12, 2022	Initial	$100,000	No comparison	1	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-544749

Source: Form D, filed Apr 30, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
James A Bruce, Jr.	Director, Executive
Greg Downey	Director
Dan Justin	Director
Daniel F Justin	Director
Justin Kaler	Director
Matt Milanowski	Director
Donald Running	Director, Executive
Connor Sullivan	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

9575 Nevada Trail
Missoula, MT, 59808